13
Participants
Start Date
September 26, 2017
Primary Completion Date
February 13, 2019
Study Completion Date
May 23, 2019
anakinra
sub cutaneous injection
Placebo
sub cutaneous injection
Hospital for Special Surgery, New York
Columbia University Medical Center, New York
Children's Hospital of Pittsburgh of UPMC, Pittsburgh
Virginia Commonwealth University, Richmond
Wake Forest Baptist Brenner Medical Center, Winston-Salem
UNC Hospitals, Chapel Hill
Duke Children's Hospital and Health Center, Durham
University of Florida, Gainesville
University of Miami, Miami
Nicklaus Children's Hospital, Miami
University of Alabama Birmingham, Birmingham
Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville
University of Louisville School of Medicine Research Foundation, Louisville
Nationwide Children's Hospital, Columbus
MetroHealth System, Cleveland
University of Michigan, Ann Arbor
University of Iowa Hospitals and Clinics, Iowa City
Medical College of Wisconsin, Milwaukee
Saint Paul Rheumatology, Eagan
University of Minnesota, Minneapolis
Saint Louis University, St Louis
Children's Mercy Hospital and Clinics, Kansas City
Baylor Research Institute, Dallas
Univ of TX Southwestern Medical Center Dallas - Texas Scottish Rite Hospital for Children, Dallas
Texas Children's Hospital, Houston
University of Texas Health Science Center at San Antonio, San Antonio
The Children's Hospital Colorado, Aurora
University of Utah Hospitals and Clinics, Salt Lake City
Attune Health, Beverly Hills
Rady Children's Hospital & Health Center, San Diego
University of Washington, Seattle
Beth Israel Deaconess Medical Center, Boston
Boston Children's Hospital, Boston
Hackensack University Medical Center, Hackensack
Institute for Rheumatic and Autoimmune Diseases, Summit
University of Vermont Medical Center, Burlington
University of Calgary - Alberta Children's Hospital, Calgary
University of Calgary, Calgary
The Hospital for Sick Children, Toronto
Lead Sponsor
Swedish Orphan Biovitrum
INDUSTRY